The purchase of Metro AG’s Galeria Kaufhof stores is Hudson’s Bay’s first under its joint venture with Simon Property Group, marking a new era of real-estate fueled growth as retailers try to squeeze more value from their property.
Intarcia Therapeutics Inc. is betting its matchstick-size pump could take market share from Eli Lilly and Co., AstraZeneca Plc and Novo Nordisk A/S.
Democrats handed President Barack Obama an embarrassing defeat on his trade agenda, blocking final passage of fast-track negotiating authority just hours after he made a rare visit to Capitol Hill to seek their support.
Axovant Sciences Ltd., a company without a finished product or a dime of sales, has an almost $3 billion valuation after its public-market debut. The IPO shows the staggering potential for any company that can develop a successful Alzheimer’s treatment.
The Obama administration is poised to deliver a victory to engine makers at the expense of truck manufacturers such as Cummins Inc. in the next stage of the U.S. government’s plan to tackle climate change.
Already considered one of the largest thefts of U.S. government personnel data in history, investigators now estimate that it may include data on as many as 14 million people, including every federal employee.
Subaru, which has thousands of workers in Indiana, has never seen so much demand from car buyers. But making big moves to boost output could hurt the very thing that customers love about the automaker—its smaller size.
Eli Lilly stock rose 5.4 percent per share on Tuesday, its biggest daily increase since March 2009, after Elanco President Jeffrey Simmons was asked if Lilly might one day shed the unit in an initial public offering.
Humana Inc. has pulled out of a major health care conference and said it will not comment on rumors of a merger, actions that will likely fuel Wall Street speculation that the insurer is part of a developing deal. Anthem Inc. is a possible suitor.
Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.
An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.
Steelmakers including Indiana-based Steel Dynamics Inc. filed a trade complaint alleging that imports of corrosion-resistant metal from China and four other countries are being sold in the U.S. at unfairly low prices.
Charter Communications Inc.’s proposed purchase of Time Warner Cable Inc. faces fewer hurdles to U.S. regulatory approval than Comcast Corp.’s ill-fated bid to buy the No. 2 cable provider.
The drugmaker plans to sell 2.1 billion euros ($2.3 billion) of securities in three parts, according to a person familiar with the matter who asked not to be identified.
The Indiana Finance Authority is paying about $71 million to Goldman Sachs Group Inc. to end an interest-rate swap as part of a bond sale to refinance debt for Lucas Oil Stadium. An additional $34.7 million is being paid for the Indiana Convention Center.
The New England Patriots’ attorney said the conclusions of the Wells Report, which led to a four-game suspension for quarterback Tom Brady and $1 million fine for the team, are “incomplete, incorrect and lack context.”
The jobless rate fell to the lowest level since May 2008 as more Americans entered the labor force and found work. Average hourly earnings climbed less than forecast.
Microsoft Corp. is evaluating a bid for Salesforce.com Inc., after the cloud software provider was approached by another would-be buyer, people with knowledge of the matter said.
Charter Communications Inc.’s deal to buy Bright House for $10.4 billion is now in jeopardy because it had depended on Comcast Corp. closing its now-defunct merger with Time Warner Cable Inc.
Two former National Football League players who challenged Cleveland’s tax on their income won refunds after the Ohio Supreme Court ruled the way the city calculated their taxes was improper.
